Bivalent Covid-19 Vaccines - A Cautionary Tale
- PMID: 36630616
- DOI: 10.1056/NEJMp2215780
Bivalent Covid-19 Vaccines - A Cautionary Tale
Comment in
-
Bivalent Covid-19 Vaccines.N Engl J Med. 2023 Mar 23;388(12):1151. doi: 10.1056/NEJMc2301323. Epub 2023 Mar 1. N Engl J Med. 2023. PMID: 36856582 No abstract available.
-
Bivalent Covid-19 Vaccines. Reply.N Engl J Med. 2023 Mar 23;388(12):1151-1152. doi: 10.1056/NEJMc2301323. Epub 2023 Mar 1. N Engl J Med. 2023. PMID: 36856583 No abstract available.
Similar articles
-
BA.1 Bivalent COVID-19 Vaccine Use and Stroke in England.JAMA. 2023 Jul 11;330(2):184-185. doi: 10.1001/jama.2023.10123. JAMA. 2023. PMID: 37318811 Free PMC article.
-
Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster.N Engl J Med. 2023 Apr 13;388(15):1431-1432. doi: 10.1056/NEJMc2302134. Epub 2023 Mar 29. N Engl J Med. 2023. PMID: 36988584 Free PMC article. No abstract available.
-
Audio Interview: Assessing Bivalent Vaccines against Covid-19.N Engl J Med. 2022 Sep 29;387(13):e37. doi: 10.1056/NEJMe2212736. N Engl J Med. 2022. PMID: 36170506 No abstract available.
-
Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.Front Biosci (Landmark Ed). 2021 Nov 30;26(11):1286-1304. doi: 10.52586/5024. Front Biosci (Landmark Ed). 2021. PMID: 34856768 Review.
-
Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.RMD Open. 2021 Feb;7(1):e001553. doi: 10.1136/rmdopen-2020-001553. RMD Open. 2021. PMID: 33627439 Free PMC article. Review.
Cited by
-
COVID-19 vaccine evidence monitoring assisted by artificial Intelligence: An emergency system implemented by the Public Health Agency of Canada to capture and describe the trajectory of evolving pandemic vaccine literature.Vaccine X. 2024 Oct 24;21:100575. doi: 10.1016/j.jvacx.2024.100575. eCollection 2024 Dec. Vaccine X. 2024. PMID: 39555243 Free PMC article.
-
Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates.Nat Commun. 2024 Sep 27;15(1):8395. doi: 10.1038/s41467-024-52194-9. Nat Commun. 2024. PMID: 39333473 Free PMC article.
-
Relative effectiveness of bivalent boosters against severe COVID-19 outcomes among people aged ≥ 65 years in Finland, September 2022 to August 2023.Euro Surveill. 2024 Sep;29(37):2300587. doi: 10.2807/1560-7917.ES.2024.29.37.2300587. Euro Surveill. 2024. PMID: 39268649 Free PMC article.
-
Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants.NPJ Vaccines. 2024 Sep 9;9(1):164. doi: 10.1038/s41541-024-00950-9. NPJ Vaccines. 2024. PMID: 39251608 Free PMC article.
-
Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19: a retrospective single center study.BMC Infect Dis. 2024 Sep 3;24(1):871. doi: 10.1186/s12879-024-09765-4. BMC Infect Dis. 2024. PMID: 39223456 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical